Catalent to ramp up J&J vaccine production at Italian plant
The line is expected to be operational in the fourth quarter to support the vaccine's production through late 2022, Catalent said
The line is expected to be operational in the fourth quarter to support the vaccine's production through late 2022, Catalent said